29
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Biomonitoring of environmental tobacco smoke (ETS)-related exposure to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)

Pages 33-45 | Published online: 29 Sep 2008

Reference

  • BEGUTTER, H., KLUS, H. and ULTSCH, I. 1985, Kapillargaschromatographische Bestimmung fitichtiger und tabakspezifischer N-Nitrosamine mittels des Thermo-Energy-Analyzers. Journal of Chrornatography, 321,475–479.
  • BENOWITZ, N. L. 1996, Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiology Reviews, 18,188–204.
  • BRANNER, B., KUTZER, C, ZWICKENPFLUG, W, SCHERER, G., HELLER, W D. and RICHTER, E. 1998, Haemoglobin adducts from aromatic amines and tobacco-specific nitrosamines in pregnant smoking and nonsmoking women. Biomarkers, 3,35–47.
  • BRUNNEMANN, K. D., COX, J. E. and HOFFMANN, D. 1992, Analysis of tobacco-specific N-nitrosamines in indoor air. Cardnogenesis, 13,2415–2418.
  • CARMELLA, S. G., AKERKAR, S. and HECHT, S. S. 1993, Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone in smokers' urine. Cancer Research, 53, 721–724.
  • CARMELLA, S. G., AKERKAR, S. A., RICHIE JR., J. P and HECHT, S. S. 1995, Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone (NNK) in smokers' urine. Cancer Epidemiology, Biomarkets & Prevention, 4,635–642.
  • CARMELLA, S. G., BORUKHOVA, A., AKERKAR, S. A. and HECHT, S. S. 1997, Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone a tobacco-specific lung carcinogen. Cancer Epidemiology, Biomarlcers & Prevention, 6, 113–120.
  • COULTAS, D. B., SAMET, J. M., MCCARTHY, J. E and SPENGLER, J. D. 1990, Variability of measures of exposure to environmental tobacco smoke in the home American Review of Respinuoty Diseases, 142, 602–606.
  • FALTER, B., KUTZER, C and RICHTER, E. 1994, Biomonitoring of hemoglobin adducts: aromatic amines and tobacco-specific nitrosamines. The Clinical Investigator, 72, 364–371.
  • HACKSHAW, A. K., LAW, M. R. and WALD, N. J. 1997, The accumulated evidence on lung cancer and environmental tobacco smoke. British Medical Journal, 315, 980–988.
  • HALEY, N. J., AXELRAD, C M. and TILTON, K. A. 1983, Validation of self-reported smoking behaviour: biochemical analyses of cotinine and thiocyanate. American Journal of Public Health, 73, 1204–1207.
  • HALEY, N. J., SEPKOVIC, D. W. and HOFFMANN, D. 1989, Elimination of cotinine from body fluids: disposition in smokers and nonsmokers. American Journal of Public Health, 79, 1046–1048.
  • HECHT, S. S. 1996, Recent studies on mechanisms of bioactivation and detoxification of 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone (NNK), a tobacco-specific lung carcinogen. Critical Reviews in Toxicology, 26, 163–181.
  • HECHT, S. S., CARMELLA, S. G., FOILES, P G., MURPHY, S. E. and PETERSON, L. A. 1993a, Tobacco-specific nitrosamine adducts: studies in laboratory animals and humans Environmental Health Perspectives, 99, 57–63.
  • HECHT, S. S., CARMELLA, S. G., MURPHY, S. E., AKERKAR, S., BRUNNEMANN, K. D. and HOFFMANN, D. 1993b, A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. The New England Journal of Medicine, 329, 1543–1546.
  • HECHT, S. S., CHUNG, E L., RICHIE JR., J. P, AKERKAR, S. A., BORUKHOVA, A., SKOWRONSKI, L. and CARMELLA, S. G. 1995, Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers. Cancer Epidemiology, Biomarkers & Prevention, 4, 877–884.
  • HOFFMANN, D. and HOFFMANN, I. 1997, The changing cigarette, 1950-1995. Journal of Toxicology and Environmental Health, 50,307–364.
  • HOFFMANN, D., RIVENSON, A. and HECHT, S. S. 1996, The biological significance of tobacco-specific N-nitrosamines: smoking and adenocarcinoma of the lung. Critical Reviews in Toxicology, 26, 199–211.
  • KLUS, H., BEGUTTER, H., SCHERER, G., TRICKER, A. R. and ADLKOFER, E 1992, Tobacco-specific and volatile N-nitrosamines in environmental tobacco smoke of offices. Indoor Environment, 1, 348–350.
  • KRULL, I. S., GOFF, E. U., HOFFMAN, G. G. and FINE, D. H. 1979, Confirmatory methods for the thermal energy determination of N-nitroso compounds at trace levels. Analytical Chemistry, 51, 1706–1709.
  • KYEREMATEN, G. A., DAMIANO, M. D., DVORCHIK, B. H. and VESELL, E. S. 1982, Smoking-induced changes in nicotine disposition: application of a new HPLC assay for nicotine and its metabolites. Clinical Pharmacology and Therapeutics, 32,769–780.
  • MEGER, M., MEGER, KOSSIEN, I., DIETRICH, M., TRICKER, A. R., SCHERER, G. and AD LKOFER, E 1996, Metabolites of 4-(N-methylnitrosamino)-1-(3-pyridy1)-1-butanone in urine of smokers. European Journal of Cancer Prevention, 5 (Supp. 1), 121–124.
  • OGDEN, M. W. and MAIOLO, K. C 1992, Comparative evaluation of diffusive and active sampling systems for determining airborne nicotine and 3-ethenylpyridine. Environmental Science & Technology, 26, 1226–1234.
  • OLDAKER III, G. B., PERFETTI, P. E, CONRAD, E C and CONNER, J. M. 1990, Results from surveys of environmental tobacco smoke in offices and restaurants. In Indoor Air Quality, H. Kasuga, ed. (Berlin, Heidelberg, New York: Springer), pp. 99–104.
  • PARSONS, W D., CARMELLA, S. G., AKERKAR, S., BONILLA, L. E. and HECHT, S. S. 1998, A metabolite of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone in the urine of hospital workers exposed to environmental tobacco smoke. Cancer Epidemiology, Biomarkets & Prevention, 7,257–260.
  • PHILLIPS, K., HOWARD, D. A., BENTLEY, M. C and ALVAN, G. 1998, Measured exposures by personal monitoring for respirable suspended particles and environmental tobacco smoke of housewives and office workers resident in Bremen, Germany. International Atrhives of Occupational and Environmental Health, 71,201–212.
  • RICHIE JR., J. P, CARMELLA, S. G., MUSCAT, J. E., SCOTT, D. G., AKERKAR, S. A. and HECHT, S. S. 1997, Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanoene in black and white smokers. Cancer Epidemiology, Biomarkers & Prevention, 6,783–790.
  • RICHTER, E. and TRICKER, A. R. 1994, Nicotine inhibits the metabolic activation of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone in rats. Cardnogenesis, 15, 1061–1064.
  • SCHERER, G. and RICHTER, E. 1997, Biomonitoring exposure to environmental tobacco smoke (ETS): a critical reappraisal. Human and Experimental Toxkology, 16,449–459.
  • SCHERER, G., CONZE, C, V. MEYERINCK, L., SORSA, M. and ADLKOFER, E 1990, Importance of exposure to gaseous and particulate phase components of tobacco smoke in active and passive smokers. International Archives of Occupational and Environmental Health, 62,459–466.
  • SCHERER, G., RUPPERT, T., DAUBE, H., KOSSIEN, I., RIEDEL, K., TRICKER, A. R. and ADLKOFER, E 1995, Contribution of tobacco smoke to environmental benzene exposure in Germany. Environment International, 21, 779–789.
  • SCHULZE, J., RICHTER, E., BINDER, U. and ZWICKENPFLUG, W. 1992, Biliary excretion of 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone in the rat. Catrinogenesis, 13, 1961–1965.
  • SCHULZE, J., SCHRADER, E., FOTH, H., KAHL, G. E and RICHTER, E. 1998, Effect of nicotine of cotinine on metabolism of 4-methylnitrosamino-1-(3-pyridy1)-1-butanone (NNK) in isolated rat lung and liver. Naunyn Schmiedeberg's Atrhives of Pharmacology, 357, 344–350.
  • TRICKER, A. R., DITRICH, C and PREUSSMANN, R. 1991, N-Nitroso compounds in cigarette tobacco and their occurrence in mainstream tobacco smoke. Carcinogenesis, 12,257–261.
  • TRICKER, A. R., KLU S, H., BEGUTTER, H., RUPPERT, T., SCHERER, G. and ADLKOFER, E 1994, Tobacco-specific and volatile nitrosamines in indoor air of smoker and nonsmoker homes In Indoor Air Pollution. Proceedings of the International Conference held at the University of Ulm, Ulm, Germany, 5–7 October 1994, L. Weber, ed. (Rotheniluh, Switzerland: Indoor Air International), pp. 310–316.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.